Bharat Biotech concludes final analysis for COVAXIN, claims 77.8 pc efficacy from phase-3 clinical trials
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
Hyderabad, Jul 3 (UNI): Bharat Biotech, a global leader in vaccine development and innovation, announced on Saturday safety and efficacy ...
© Janam Multimedia Limited